The Discounted Cash Flow (DCF) valuation of SCI Pharmtech Inc (4119.TW) is 33.46 TWD. With the latest stock price at 64.10 TWD, the upside of SCI Pharmtech Inc based on DCF is -47.8%.
Based on the latest price of 64.10 TWD and our DCF valuation, SCI Pharmtech Inc (4119.TW) is a sell. selling 4119.TW stocks now will result in a potential gain of 47.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 8.0% | 6.5% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 15.97 - 237.52 | 33.46 |
| Upside | -75.1% - 270.5% | -47.8% |